Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Oral & Dental

In vitro effects of dual wavelength photobiomodulation on monocytic response in painful temporomandibular disorder

These results provide additional evidence for PBM as a benign and non-invasive technique to control and potentially modify TMD-related inflammation.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied monocytes isolated from 16 people with painful temporomandibular disorder, cultured in vitro with lipopolysaccharide and treated with a dual-wavelength photobiomodulation protocol. They report reduced levels of several pro-inflammatory mediators and increased levels of some regulatory mediators, suggesting a shift toward an anti-inflammatory profile. Because the work was done on cells in culture, its relevance to living patients is uncertain.

Participants
16
Who or what was studied
Monocytes isolated from 16 individuals with painful temporomandibular disorder enrolled in a randomized, placebo-controlled clinical trial
Wavelengths
810, 660, 850, 180 nm
Limits stated in the abstract
The study was conducted in vitro on cultured cells, so findings may not translate directly to clinical outcomes in patients.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Temporomandibular disorders (TMD) are a prevalent source of chronic pain and disability, yet current therapies often provide limited relief with notable side effects. Photobiomodulation (PBM) has emerged as a promising non-pharmacologic approach to modulate inflammation and pain. This study investigated the effects of a dual-wavelength PBM protocol (laser + light-emitting diode (LED)) on the lipopolysaccharide (LPS)-stimulated monocyte response from individuals with painful TMD. Monocytes were isolated from 16 individuals with TMD enrolled in a randomized, placebo-controlled clinical trial (NCT05916235). Cells were plated into 96-well plates and divided into Control, LPS, and LPS + PBM treatment groups. Monocytes received four alternating-day treatments with two PBM probes: a laser probe (810/660 nm, 180 J/cm2) and an LED probe (660/850 nm). Cytokine and chemokine levels in culture supernatants were measured via multiplexed immunoassays. To verify cell viability after PBM treatment, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was used. Statistical analysis was conducted using one-way analysis of variance (ANOVA) with Bonferroni correction, and p < 0.05 was considered significant. PBM significantly reduced levels of pro-inflammatory mediators interleukin-1 beta (IL-1β) (p = 0.005), C-X-C motif chemokine ligand 9 (CXCL9) (p = 0.0042), interferon gamma-induced protein 10 (IP-10) (p = 0.001), and tumor necrosis factor-alpha (TNF-α) (p = 0.0003), while increasing expression of regulatory mediators interleukin-10 (IL-10) (p = 0.0009), interleukin-1 receptor antagonist (IL-1RA) (p = 0.004), and CC motif chemokine ligand 17 (CCL17) (p = 0.003). These findings suggest that the dual-wavelength PBM protocol was able to shift the monocyte immune response from a more pro-inflammatory (M1) phenotype to a more anti-inflammatory, tissue-repair (M2) cytokine profile. These results provide additional evidence for PBM as a benign and non-invasive technique to control and potentially modify TMD-related inflammation. ClinicalTrials.gov ID: NCT05916235.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
660 nm, 850 nm
Energy density (fluence)
180 J/cm2

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Wavelength, Light-emitting diode, Inflammation, Laser, Placebo-controlled. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies